pharma news today obesity drug glp-1 Agonists Weight Loss Drugs Market Report, 2025-2030 Data Brief: GLP-1 Prescriptions for

doi:10.1136/jcp.56.12.924 Hamaguchi Y, Kondoh T, Fukuda M, et al

'Game changers' with future cost savings Most private insurers dont cover GLP-1s for weight loss, which can make the drugs unaffordable for those paying out of pocket

Model development and feature selection process To determine the best methodology for our task, several common ML algorithms and feature sets were tested

Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise

This unique mechanism gives cagrilintide a distinct role in weight loss regimens, especially when combined with GLP-1 receptor agonists